Neuroprotection by astrocytes in brain ischemia: importance of microRNAs

Yi-Bing Ouyang1, Lijun Xu1, Sibiao Yue2

  • 1Department of Anesthesia, Stanford University School of Medicine, Stanford, CA 94305, USA.

Neuroscience Letters
|November 26, 2013
PubMed

Insights

Manipulating astrocyte functions via astrocyte-enriched microRNAs (miRNAs) shows promise for improving outcomes after cerebral ischemia. This review highlights key miRNAs and their targets for enhancing neuronal survival.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Astrocytes play a crucial role in neuroprotection and neuronal survival, particularly in pathological conditions like cerebral ischemia.
  • Modulating astrocyte functions represents a promising therapeutic strategy to improve recovery after brain injury.
  • MicroRNAs (miRNAs), including astrocyte-enriched ones, are increasingly recognized for their regulatory roles in cerebral ischemia.

Purpose of the Study:

  • To review recent findings on astrocyte-enriched microRNAs (miRNAs) involved in cerebral ischemia.
  • To discuss specific miRNAs, including miR-181, miR-29 families, and miR-146a, their validated targets, and regional expression.
  • To evaluate the impact of these astrocyte-enriched miRNAs on outcomes following cerebral ischemia.

Main Methods:

  • Literature review of recent scientific publications.
  • Focus on astrocyte-enriched microRNAs (miRNAs) such as miR-181, miR-29 families, and miR-146a.
  • Analysis of validated miRNA targets, regional expression patterns, and functional effects on cerebral ischemia outcomes.

Main Results:

  • Several astrocyte-enriched miRNAs (miR-181, miR-29 families, miR-146a) are implicated in regulating cerebral ischemia.
  • These miRNAs target key pathways involved in neuronal survival and inflammation.
  • Specific miRNAs show distinct regional expression patterns and influence recovery after ischemic events.

Conclusions:

  • Astrocyte-enriched miRNAs are significant regulators of neuronal survival and outcome in cerebral ischemia.
  • Targeting these specific miRNAs offers a potential therapeutic avenue for treating ischemic stroke.
  • Further research into miRNA-astrocyte interactions is warranted for developing novel neuroprotective strategies.